Literature DB >> 24419124

Timing versus duration of adjuvant therapy for pancreatic cancer: all the lessons we need in life are taught to us as children.

Emily Chan1, Jordan Berlin.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24419124     DOI： 10.1200/JCO.2013.53.5617

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  The Yonsei criteria as a clinically detectable parameter for excellent prognosis in resected left-sided pancreatic cancer: outcomes of a propensity score-matched analysis.

Authors:  Sung Hwan Lee; Ho Kyoung Hwang; Chang Moo Kang; Woo Jung Lee
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

2.  GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma.

Authors:  Fenja M Feld; Philipp D Nagel; Stephanie E Weissinger; Claudia Welke; Albrecht Stenzinger; Peter Möller; Jochen K Lennerz
Journal:  Oncotarget       Date:  2015-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.